Glassman Wealth Services’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-113
Closed -$19K 1918
2021
Q2
$19K Sell
113
-26
-19% -$4.34K ﹤0.01% 594
2021
Q1
$21K Buy
139
+1
+0.7% +$136 ﹤0.01% 523
2020
Q4
$17K Buy
138
+11
+9% +$1.23K ﹤0.01% 583
2020
Q3
$13K Buy
127
+79
+165% +$8.05K ﹤0.01% 558
2020
Q2
$5K Buy
48
+44
+1,100% +$4.09K ﹤0.01% 654
2020
Q1
$0 Sell
4
-3
-43% -$293 ﹤0.01% 1724
2019
Q4
$1K Buy
7
+4
+133% +$411 ﹤0.01% 1118
2019
Q3
$0 Hold
3
﹤0.01% 1505
2019
Q2
$0 Hold
3
﹤0.01% 1490
2019
Q1
$0 Hold
3
﹤0.01% 1261
2018
Q4
$0 Hold
3
﹤0.01% 1048
2018
Q3
$0 Hold
3
﹤0.01% 1004
2018
Q2
$0 Hold
3
﹤0.01% 1003
2018
Q1
$0 Hold
3
﹤0.01% 982
2017
Q4
$0 Buy
+3
New +$250 ﹤0.01% 838

Other funds holding PRAH

Glassman Wealth Services's PRAH Position: Q3 2021 in Review

Glassman Wealth Services sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 113 shares — an estimated $19K sold.

Glassman Wealth Services first reported a position in PRAH in Q4 2017 and held it in 15 quarters. The position peaked at $21K in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Glassman Wealth Services reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Glassman Wealth Services sold 113 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $19K.
  • Glassman Wealth Services first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 15 quarters.
  • Glassman Wealth Services's PRA Health Sciences, Inc. position peaked at $21K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Glassman Wealth Services's 13F filing for Q3 2021, filed 10 Nov 2021.